Discovered more than 30 years ago, the angiotensin AT 2 receptor (AT 2 R) has evolved
from a binding site with unknown function to a firmly established major effector within the …

The neuroprotective effects of menopausal hormonal therapy in Parkinson's disease (PD)
have not yet been clarified, and it is controversial whether there is a critical period for …

There is a lack of consensus about the effects of the type of menopause (surgical or natural)
and of oestrogen replacement therapy on Parkinson's disease. The effects of the timing of …

Many painful conditions occur more frequently in women, and estrogen is a predisposing
factor. Estrogen may contribute to some pain syndromes by enhancing axon outgrowth by …

We studied the effect of ovariectomy and estrogen replacement on expression of adrenal
angiotensin II AT 1 and AT 2 receptors, aldosterone content, catecholamine synthesis, and …

The ovarian hormone, 17β-estradiol, has been suggested to play an important role in
gender-specific differences in cardiovascular diseases. One possible cardioprotective …

The angiotensin AT 2 receptor (AT2R) represents an important component of the renin-
angiotensin system since it is involved in the (patho) physiology of different cardiovascular …

Pregnancy is characterized by a progressive increase in the di ferent components of the
renin angiotensin system (RAS) including angiotensin II, a potent vasoconstrictor. Pregnant …

Breast cancer is one of the most common forms of cancer observed in women and
endogenous estrogens are thought to play a major role in its development. Tamoxifen is a …

Angiotensin II (Ang II) functions through two major Ang II receptor subtypes, type 1 (AT1‐R)
and type 2 (AT2‐R), both of which are classified to be G protein‐coupled receptors. AT2‐R is …